Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD by Hanson, B, Stenler, S, Ahlskog, N, Chwalenia, K, Svrzikapa, N, Coenen-Stass, AML, Weinberg, MS, Wood, MJA, Roberts, TC

Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties by Chwalenia, K, Oieni, J, Zemła, J, Lekka, M, Ahlskog, N, Coenen-Stass, AML, McClorey, G, Wood, MJA, Lomonosova, Y, Roberts, TC

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy by Winkelsas, AM, Grunseich, C, Harmison, GG, Chwalenia, K, Rinaldi, C, Hammond, SM, Johnson, K, Bowerman, M, Arya, S, Talbot, K, Wood, MJ, Fischbeck, KH

Dystrophin involvement in peripheral circadian SRF signalling by Betts, CA, Jagannath, A, van Westering, TLE, Bowerman, M, Banerjee, S, Meng, J, Falzarano, MS, Cravo, L, McClorey, G, Meijboom, KE, Bhomra, A, Lim, WF, Rinaldi, C, Counsell, JR, Chwalenia, K, O’Donovan, E, Saleh, AF, Gait, MJ, Morgan, JE, Ferlini, A, Foster, RG, Wood, MJA